Kim Clijsters Reacts to Tara Moore’s $20M Lawsuit Against WTA

Tara Moore in a courtroom setting during legal proceedings involving a lawsuit with the WTA.

The Tara Moore case refuses to stay confined to paperwork and legal briefs. It has become a fault line running through modern tennis — science on one side, strict liability on the other.

Kim Clijsters, former world No. 1 and seven-time Grand Slam champion, did not rush to courtroom theatrics. Instead, she called the situation “very, very disappointing” and framed Moore’s $20 million lawsuit against the WTA as a symptom of deeper structural tension within the sport.

The Science That Turned the Case

Moore, 33, reached career highs of No. 145 in singles and No. 77 in doubles before testing positive in 2022 for the anabolic steroids boldenone and nandrolone. In December 2023, an independent tribunal cleared her of “fault and negligence.” It looked, briefly, like resolution.

Then the International Tennis Integrity Agency appealed. Last July, the Court of Arbitration for Sport imposed a four-year ban.

At the heart of CAS’s ruling was concentration. The nandrolone levels detected in Moore’s sample were deemed too high to be plausibly explained by contaminated meat.

Clijsters pointed directly at that finding. “I do think the ITIA based their conclusion or decision on the fact that they said the levels were too high to have been contaminated by meat. Specifically with the nandrolone.”

In anti-doping cases, numbers are destiny. If scientific panels conclude the concentration exceeds what unintentional ingestion would produce, mitigation narrows sharply. Once CAS accepts that logic, reversing it becomes a steep climb.

The Gap Between Suspicion and Proof

Moore now argues the WTA failed to adequately protect players from the risk of contaminated meat at events, particularly in South America. Her lawsuit shifts scrutiny away from anti-doping bodies and onto tour governance.

Clijsters, who previously served on the WTA Board, was careful not to speculate on the lawsuit’s prospects. “Will it be $20 million? I don’t think so,” she said.

Her focus was practical rather than legal. How do you verify contamination once a tournament has ended? How do you independently test food sources weeks or months later?

“If she is innocent, how difficult is it to test the meat, and how difficult is it to check what effect that has on the body?” Clijsters asked. “It’s just a very frustrating situation.”

That frustration lies in the gap between suspicion and proof. Under the anti-doping code, strict liability applies. Intent is irrelevant. Presence alone can be enough.

How Much Can a Tour Control?

Clijsters also outlined the limits of tour oversight. “I know the WTA tries their very best when it comes to making sure all tournaments and tournament directors are aware of the risks and the catering services that are working for the tournaments.”

She described tour officials as deeply involved in safeguarding player welfare, from food standards to availability. Yet global calendars mean shifting jurisdictions, varying regulations, and uneven supply chains.

Players falling ill due to food quality is not unheard of. Eliminating every variable across continents may be unrealistic.

“I don’t think the WTA can do much about those things,” Clijsters admitted, before adding, “We’ll see how that turns out.”

The broader implication is clear. If tours face litigation tied to food safety, catering protocols may tighten further. On the ATP side, some events have reportedly removed red meat from menus in certain regions as a precaution.

Career Time and Human Cost

Beyond governance and science lies time — the one asset elite sport rarely restores. A four-year ban at 33 is not a pause. It is an erasure of competitive prime.

“It’s a very, very unfortunate and disappointing situation for every party,” Clijsters said. “If it’s because of contaminated meat, it’s a very, very sad situation, and that she’s being punished for it is just very, very unfortunate.”

She did not present Moore as villain or martyr. Instead, she cast the case as emblematic of modern tennis’s uneasy balance between athlete responsibility, scientific thresholds, and institutional protection.

As Moore pursues damages and the legal process unfolds, the sport confronts uncomfortable questions. How much protection can a global tour realistically provide? How definitive are scientific cutoffs? And who bears the burden when gray zones turn punitive?

For now, the case sits at the intersection of governance and human consequence. However it resolves, the aftershocks will travel well beyond one player’s ranking.

Dura lex, sed lex?
Sometimes too harsh.